Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB01030_DB04868> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB01030_DB04868 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB01030_DB04868 label "DDI between Topotecan and Nilotinib - The p-glycoprotein inhibitor, Nilotinib, may increase the bioavailability of oral Topotecan. A clinically significant effect is also expected with IV Topotecan. Concomitant therapy should be avoided. [drugbank_resource:DB01030_DB04868]" assertion.
- drugbank_resource:DB01030_DB04868 identifier "drugbank_resource:DB01030_DB04868" assertion.
- drugbank_resource:DB01030_DB04868 title "DDI between Topotecan and Nilotinib - The p-glycoprotein inhibitor, Nilotinib, may increase the bioavailability of oral Topotecan. A clinically significant effect is also expected with IV Topotecan. Concomitant therapy should be avoided." assertion.